×
Welcome to the Author's Centre and thank you for considering EuroIntervention (EIJ) as the home for your manuscript. In this section you will find basic ...
Missing: dawn- abbott
J. Dawn Abbott has nothing to disclose. Lina Badimon reports grants from AstraZeneca, other from Sanofi, grants from A-Biotics, other from Lilly, other from ...
People also ask
PCRonline · PCR-EAPCI Textbook · AsiaIntervention. Services ... Dawn Abbott7, MD; Sammy Elmariah2, MD, MPH; Gregg ... Available at: https://www.hcup-us.ahrq.gov/db ...
The authors aimed to investigate comparative in-hospital outcomes of younger patients <75 years old undergoing transfemoral (TF) TAVR or isolated SAVR. Methods ...
This review highlights the most relevant randomised trials and original research studies related to coronary interventional practice over the last year.
Left atrial appendage occlusion or exclusion in AF34-50 is based on the concept that only ~10% of clinically relevant emboli in non-valvular AF do not originate ...
This study developed a 9-variable prediction model for 30-day readmission risk after transcatheter aortic valve replacement (TAVR) using national US ...
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Missing: dawn- abbott
Chapter 1. Background and pathophysiology of thrombus formation in the left atrium. The rationale for the quest to close the left atrial appendage (LAA) for ...
A study of 202 patients evaluating the safety of left atrial appendage occlusion with aspirin monotherapy over 266 patient-years in patients at high risk of ...